(Q79080814)

English

Isolated limb perfusion with tumor necrosis factor‐α and melphalan for patients with unresectable soft tissue sarcoma of the extremities

scientific article published on 01 October 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14508836%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14508836%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Isolated limb perfusion with tumor necrosis factor‐α and melphalan for patients with unresectable soft tissue sarcoma of the extremities (English)

1 reference

10.1002/CNCR.11648

https://api.crossref.org/works/10.1002/CNCR.11648

14 March 2024

1 reference

10.1002/CNCR.11648

https://api.crossref.org/works/10.1002/CNCR.11648

14 March 2024

author name string

Frits van Coevorden

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14508836%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Eva M. Noorda

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14508836

14 March 2024

Bart C. Vrouenraets

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14508836

14 March 2024

Omgo E. Nieweg

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14508836

14 March 2024

Gooike W. van Slooten

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14508836

14 March 2024

Bin B. R. Kroon

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14508836

14 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14508836

14 March 2024

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14508836%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

full work available at URL

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.11648

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14508836

14 March 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.11648

1 reference

10.1002/CNCR.11648

https://api.crossref.org/works/10.1002/CNCR.11648

14 March 2024

https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.11648

1 reference

10.1002/CNCR.11648

https://api.crossref.org/works/10.1002/CNCR.11648

14 March 2024

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14508836%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

98

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14508836%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14508836%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1483-1490

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14508836%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Thirty-five years of isolated limb perfusion for melanoma: indications and results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of regional isolation perfusion with cytostatics in patients with soft tissue tumors of the extremities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility and efficacy of external beam radiotherapy after hyperthermic isolated limb perfusion with TNF-alpha and melphalan for limb-saving treatment in locally advanced extremity soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of amputation with limb-sparing operations for adult soft tissue sarcoma of the extremity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term morbidity after regional isolated perfusion with melphalan for melanoma of the limbs. The influence of acute regional toxic reactions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for local recurrence and survival in patients with localized extremity soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

Reproducibility of a histopathologic grading system for adult soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

High dose recombinant tumour necrosis factor (rTNFα) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: credits, debits, and future perspectives

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity and morbidity of isolated limb perfusion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of the patient with stage M0 soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

Rehabilitation for limb salvage patients: kinesiological parameters and psychological assessment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11648

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional isolation perfusion in melanoma of the limbs; accomplishments, unsolved problems, future

15

1 reference

10.1002/CNCR.11648

https://api.crossref.org/works/10.1002/CNCR.11648

14 March 2024

Identifiers

10.1002/CNCR.11648

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14508836%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14508836%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79080814&oldid=2101734014"